ANN ARBOR, Mich.--(BUSINESS WIRE)--LLamasoft, the leading provider of enterprise supply chain design and decision-making solutions, is proud to announce its partnership with Eversight, a nonprofit organization dedicated to restoring sight and preventing blindness through eye donation, corneal transplantation and vision research. Eversight will utilize LLamasofts solutions to make data-driven decisions that more accurately predict the future need for and availability of donated eye tissue and how to most efficiently design a delivery network to provide corneas to transplant recipients in need.
Eversight is one of the largest eye banks in the world and offers numerous services beyond traditional eye banking. The organization recovers, evaluates and delivers donated eye tissue for transplantation, supports research into the causes and cures of blinding eye conditions, promotes donation awareness through public and professional education and provides humanitarian aid to people around the world in need of sight-restoring therapies. By building a complete model of its end-to-end supply chain with LLamasoft, Eversight can more easily identify operational inefficiencies and make recommended improvements as well as evaluate contingency plans based on real-world variables that impact eye donation and transplantation. Testing and planning for various scenarios ensures that the most effective process is in place for tissue recovery, processing and delivery, and that tissue is available to surgeons and their patients when the need arises.
Eversight helps restore vision to more than 8,000 people through corneal transplantation every year, but there is more work to be done, said Ryan Simmons, Clinical Services Director at Eversight. To treat and one day eliminate preventable blindness, Eversight is collaborating with innovative partners who share our commitment to making vision a reality for people around the world. LLamasofts supply chain expertise, coupled with the insights gleaned from the data now available at our fingertips, will be invaluable in making smarter and faster decisions that ultimately will allow us to achieve more with the precious gift of sight.
This partnership enables LLamasoft to reach its commitment to positively impact 100 million lives by 2022. Eighty-nine percent of vision-impaired people live in low- and middle-income countries. Eversight is committed to meeting the need for delivery of tissues in countries where sight-restoring corneal transplant procedures would otherwise be completely unavailable, including the Middle East, Pakistan and South Korea. With LLamasofts technology identifying opportunities for cost savings, Eversight is well positioned to serve more patients in need, increase capacity to reach more corneal surgeons and effectively send more tissue overseas.
As with any transplant, time is of the essence in recovering eye tissue. In a matter of days, with Eversights help, someone who was once blind can begin to enjoy a life of sight, said Ryan Purcell, Director, Global Impact Team at LLamasoft. Eversights dedication to restoring sight and preventing blindness is truly remarkable. Assisting them in finding more effective and efficient ways to plan for, recover and deliver tissue so that more recipients can be supported is fulfilling work for our Global Impact Team. We are excited to have the opportunity to positively impact more people around the world through this collaboration.
For more information on this partnership, join Eversight in San Francisco at the Cornea and Eye Banking Forum October 11 and AAO 2019, the American Academy of Ophthalmologys annual meeting, October 12-15.
About LLamasoft, Inc.
Over 750 of the worlds most innovative companies across multiple industries rely on LLamasoft to answer complex supply chain questions. Powered by advanced analytics, LLamasoft technology helps business leaders design operational strategies to achieve profitability and growth goals. The company creates a true end-to-end view of global supply chains to enable decisions among strategic, tactical and operational time horizons. Its customers have identified more than $13B in value relying on insights from LLamasofts solutions. To reach its goal to positively impact 100 million lives by 2022, LLamasoft has partnered with humanitarian organizations, government entities and the World Economic Forum, and used its solutions to design and optimize health supply chains increase overall efficiency and reach more individuals in need.
About Eversight
Eversight is nonprofit organization with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. The Eversight network is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. Operating in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, Eversight works in collaboration with surgeons, researchers, academic medical centers and eye banks across the United States and abroad. For more information, visit eversightvision.org.
Go here to see the original:
LLamasoft Partners with Global Eye Bank, Eversight - Business Wire
- Seeing Is Believing: The Gene Therapy Breakthrough Thats Giving Sight to the Blind - SciTechDaily - September 21st, 2024
- VisiActive Review: The Natural Approach to Enhancing Your Vision and Eye Care - Bellevue Reporter - September 21st, 2024
- Does VisiActive Work? An Honest Review of Its Eye Health Claims - Kirkland Reporter - September 21st, 2024
- Sharp eye test: Only those with a perfect vision can spot the third dog in the picture - The Times of India - September 21st, 2024
- Does X Vision Really Work? An Honest Review of Its Eye Health Benefits - Islands' Sounder - September 21st, 2024
- VisiActive Review: Is This the Ultimate Supplement for Clearer, Healthier Vision? - Vashon-Maury Island Beachcomber - September 21st, 2024
- New Report Recommends Myopia Be Classified as a Disease, Policies for Children to Spend Time Outdoors - National Academies of Sciences, Engineering,... - September 21st, 2024
- X Vision Review: How Effective Is This Supplement for Enhancing Vision and Eye Health? - Kirkland Reporter - September 21st, 2024
- Elon Musk's Neuralink is working on a product called Blindsight that can restore vision: story in 5 points - India Today - September 21st, 2024
- How the eyes are windows into our health and why we should get them tested - South China Morning Post - September 21st, 2024
- UK research finds lower rate of GOS sight test activity in areas of deprivation - AOP - September 21st, 2024
- Dudley residents urged to keep an eye on their optic health - Dudley News - September 21st, 2024
- Test your eyesight: Find the odd red plane in under 7 seconds - The Times of India - August 7th, 2024
- You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes - December 30th, 2023
- How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side - October 16th, 2023
- Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now - May 17th, 2023
- Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones - April 15th, 2023
- Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference - April 15th, 2023
- GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update - April 15th, 2023
- Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow - April 15th, 2023
- Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting - April 15th, 2023
- Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference - April 15th, 2023
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023 - April 15th, 2023
- Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15th, 2023
- Alvotech Provides Regulatory Update on AVT02 Biologics License Application - April 15th, 2023
- Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 - April 15th, 2023
- Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China - April 15th, 2023
- Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting - April 15th, 2023
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023 - April 15th, 2023
- ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein - April 15th, 2023
- International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business - April 7th, 2023
- How the Human Eye Works | Cornea Layers/Role | Light Rays - NKCF.org - December 11th, 2022
- Eye Emergencies: Types, Symptoms, and Prevention - Healthline - November 25th, 2022
- The criteria for certification | RNIB - November 25th, 2022
- Foresight: Eye-Net Successfully Showcases its Advanced Solution to Leading OEMs and Tier One Suppliers in Japan - Marketscreener.com - November 25th, 2022
- Can you see me now? Average person begins worrying about their vision at age 39 - Study Finds - September 29th, 2022
- Contact lens wearers at higher risk of rare eye infection are you caring for your lenses the right way? - News24 - September 29th, 2022
- A man who popped a champagne cork into his eye says it felt like being poked 'times a thousand.' His vision was saved after months of treatment but it... - September 29th, 2022
- Whitsett Vision Group First to Use Revolutionary New Lens to Dramatically Improve Patients' Eyesight - PR Newswire - September 29th, 2022
- 'As one door closes, another opens': Adelaide man turned to yoga, meditation after major vision loss - SBS - September 29th, 2022
- Stephen Curry, whose $185,000 worth vehicle almost took his life, is sure to lose his eyesight due to a genetic defect - The Sportsrush - September 29th, 2022
- NCCVEH Names Dr. Donny W. Suh, Gavin Herbert Eye Institute, UC Irvine, as Recipient of the 8th Annual Bonnie Strickland Champion for Children's Vision... - September 29th, 2022
- XP Health Raises $17.1M Series A to Transform Vision Benefits for Insurance Carriers, Companies and Employees - PR Web - September 29th, 2022
- Everything You Need To Know About Ocular Herpes Zoster: Symptoms, Treatment, And Complications - World Nation News - September 29th, 2022
- Blurry vision turned out be tumour behind Exeter woman's eye - Devon Live - April 26th, 2022
- Woman who lost half her body weight sheds the stones for second time after sight loss - Yahoo News - April 26th, 2022
- High Schooler's Nausea Turned Out To Be Aggressive and Deadly Brain Tumor - Newsweek - April 26th, 2022
- BattleVision Storm Glasses Sees Uptick in Sales as Winter Hits - Benzinga - Benzinga - January 1st, 2022
- Insights on the Eye Care Surgical Global Market to 2026 - Featuring Abbott Laboratories, Alcon Vision and Avedro Among Others - PRNewswire - January 1st, 2022
- Monocular vision (sight in one eye) - RNIB - See differently - November 21st, 2021
- See which of your habits is actually hurting your eyesight - Yahoo News UK - November 21st, 2021
- CVRS, TEH protect the gift of sight with free eye surgeries | Loop Trinidad & Tobago - Loop News Trinidad and Tobago - November 21st, 2021
- Take More Walking to Improve Your Eyesight! - Central Recorder - November 21st, 2021
- Remedies to reduce eye strain while working from home - The Siasat Daily - November 21st, 2021
- Chris McCausland: 'I was diagnosed with retinitis pigmentosa' what is that? - Daily Express - November 21st, 2021
- 5th Graders help Pittsburg Lions Club improve vision for those in need Newstalk KZRG - newstalkkzrg.com - November 21st, 2021
- Uptick in vision problems among children could be due to screen time - Wink News - November 21st, 2021
- Lindsay Senior With Worsening Eyesight Urges Government And Optometrists To Resume OHIP Eye Care - Kawartha 411 - November 21st, 2021
- The Link Between Loneliness and Vision Impairment on Dementia - DocWire News - November 21st, 2021
- Optometrist warns of the long-term effects drinking can have on your eyes - Daily Express - November 21st, 2021
- Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week with New Educational and Community Building Initiative -... - November 21st, 2021
- Jumping spiders: Facts about the cutest arachnids on the planet - Livescience.com - November 21st, 2021
- Need a Boost on Your Eye Exam? Study Provides Early Evidence that Cocoa Sharpens Vision for Adults with Healthy Eyes - One Green Planet - July 21st, 2021
- How to Use Your iPhone to Check Eyesight and Renew Your Prescription - TechTheLead - July 21st, 2021
- 10 foods that are good for kids' eyesight - Free Press Journal - July 21st, 2021
- Reduce Eye Strain While Working From Home: Ayurveda Remedies To Deal With Computer Vision Syndrome - TheHealthSite - July 21st, 2021
- Prevent Blindness Holds 'Focus on Eye Health' National Summit - InvisionMag - July 21st, 2021
- Eye problems on the rise in India amid Covid-19 pandemic - Free Press Journal - July 21st, 2021
- Sean Moncrieff: I felt useless, frustrated and guilty after my operation - The Irish Times - July 21st, 2021
- Three Things Patients Should Know About Cataracts - Oregon Business - July 21st, 2021
- Johnson & Johnson Vision Presents Scientific Data Validating Improved Surgical Outcomes With Latest Cataract Innovations And Legacy MGD Treatment... - July 21st, 2021
- Sydney Optometrist Mosman Eye Injury Protection Vision Therapy Myopia Prevention - PRWire - July 21st, 2021
- EssilorLuxottica and the FIA reinforce their commitment to promote good vision for safer roads - GlobeNewswire - July 21st, 2021
- Genes from algae helped a blind man recover some of his vision - Livescience.com - May 27th, 2021
- Blind man regains some vision, with help from light-sensing algal protein - Science Magazine - May 27th, 2021
- Top paratriathlete carries the torch for healthy vision to Tokyo - liherald - May 27th, 2021
- A First: Blind Man's Sight Restored With Optogenetic Therapy - Medscape - May 27th, 2021
- Scientists successfully use gene therapy to restore eyesight restore eyesight, gene therapy - Open Access Government - May 27th, 2021
- What We're Reading: Restoring Eyesight; New Moderna Vaccine Indication Possible; COVID-19 Origin Investigation - AJMC.com Managed Markets Network - May 27th, 2021